Significados de transdermal nicotine en inglés

A fixed dose of transdermal nicotine will not be effective for all smokers.

Objective: To determine the efficacy of transdermal nicotine for controlling clinical disease activity in active ulcerative colitis.

Background: Ulcerative colitis is predominantly a disease of non-smokers, and transdermal nicotine is therapeutic but often results in side-effects.

Ulcerative colitis is predominantly a disease of nonsmokers, and transdermal nicotine is therapeutic but often results in adverse reactions.

Background: Cessation rates in smokers attending special clinics or their General Practitioners can be increased by transdermal nicotine (TNS).

An analysis of smokers admitted with acute coronary syndrome who received transdermal nicotine therapy and those who did not was performed.

Eight subjects were randomized in a double-blind crossover trial of 7 mg transdermal nicotine or placebo, each for 1 week.

Transdermal nicotine may help control clinical manifestations of this condition.

Transdermal nicotine therapy appears safe and does not have an effect on the mortality of patients with acute coronary syndromes.